soul trial oral semaglutide cardiovascular outcomes 2024 results mace Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 Cardiovascular outcomes trials: a paradigm

If youre worried about the long-term side effects of the GLP-1 and plan to get off at some point in the future, and you are concerned about gaining weight back, we can help

Perspectives: The new lean: how weight loss drugs will affect Healthtech startups - Read the latest news and insights from Northzone, a multi-stage venture capital fund investing in startups from seed to growth.

Expert UK guidance on managing cold sensitivity during GLP-1 treatment.

Lots of celebrities have now admitted to being on weight loss drugs

A diabetes dietitian explains what makes this drug different from Ozempic and Mounjaro.

Aim The aim of this review is to critically evaluate the experimental evidence available for cinnamon in improving glycaemic targets in animal models and humans